03.03.2023 • News

Aenova Appoints Hanno Scheffczik as Managing Director of its Marburg Site

Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma, a member of the Aenova Group. Effective Mar. 1, 2023, he succeeds Alfred Veit, who is retiring.

With around 150 employees, the Aenova site in Marburg manufactures delayed-release tablets and capsules as well as moisture-sensitive dosage forms.

Scheffczik studied chemistry with a focus on biochemistry and earned his doctorate at the Institute of Virology at Philipps University in Marburg. After holding various development and management positions at international research-based pharmaceutical companies, he joined Aenova in 2021, initially as Head of Manufacturing Science & Technology.

"With Dr. Scheffczik we have a long-standing experienced manager and expert who knows the industry and Aenova very well," commented Jan Kengelbach, CEO of Aenova.

Hanno Scheffczik, Managing Director, Temmler Pharma (a member of the Aenova... — Hanno Scheffczik, Managing Director, Temmler Pharma (a member of the Aenova Group). Source: Aenova Group

Company

Aenova Holding GmbH

Berger Strasse 8-10
82319 Starnberg
Germany

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing